Stem cells for the prevention of neonatal lung disease

Preterm birth affects approximately 11% of all newborns worldwide and is a major risk factor for infant mortality and morbidity. A common complication of preterm birth is the chronic lung disease of prematurity called bronchopulmonary dysplasia (BPD). Due to the lack of a specific treatment for BPD,...

Full description

Saved in:

Bibliographic Details
Published in:	Neonatology (Basel, Switzerland) Vol. 107; no. 4; p. 360
Main Authors:	O'Reilly, Megan, Thébaud, Bernard
Format:	Journal Article
Language:	English
Published:	Switzerland 01-01-2015
Subjects:	Animals Animals, Newborn Bronchopulmonary Dysplasia - prevention & control Clinical Trials as Topic Disease Models, Animal Humans Infant Infant, Newborn Infant, Premature - growth & development Rats Stem Cell Transplantation
Online Access:	Get more information
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	Preterm birth affects approximately 11% of all newborns worldwide and is a major risk factor for infant mortality and morbidity. A common complication of preterm birth is the chronic lung disease of prematurity called bronchopulmonary dysplasia (BPD). Due to the lack of a specific treatment for BPD, preterm infants surviving with BPD face a lifelong risk of poor lung health. The therapeutic potential of stem cells in regenerative medicine is being harnessed for many diseases, including BPD. Compelling preclinical data using stem cells to prevent/repair lung damage in animal models of experimental BPD has built the basis for its translation into the clinic in preterm infants. This review highlights the exciting translation from bench to bedside that will hopefully lead in the near future to improved pulmonary outcomes in preterm infants.
ISSN:	1661-7819
DOI:	10.1159/000381135